Pfizer : PFE

All Pfizer Articles

1465 Articles

Vince Calio | May 8, 2014 at 10:53 AM EDT

The Best-Selling Products of All Time

ThinkstockCreating the most popular product of the year will make consumers and investors happy. But making an all-time bestseller can…

Paul Ausick | May 6, 2014 at 4:01 PM EDT

The 4 Stocks That Tanked the Market

thinkstockMay 6, 2014: Markets opened lower on Monday and sank slowly and surely for the rest of the day. The…

Paul Ausick | May 6, 2014 at 11:05 AM EDT

Cross-Border Premium Implications in Merck-Bayer Transaction

Merck has had its consumer products business on the market since the beginning of this year, and Tuesday it announced…

Paul Ausick | May 5, 2014 at 4:01 PM EDT

The 4 Stocks That Moved the Markets

thinkstockMay 5, 2014: Markets opened lower on Monday but gamely pushed to the upside in midafternoon. General concern over the…

Paul Ausick | May 5, 2014 at 8:00 AM EDT

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

Drug giant Pfizer reported better-than-expected first-quarter 2014 earnings before markets opened Monday morning, but revenues fell short. Shares traded lower…

Jon C. Ogg | May 4, 2014 at 10:32 AM EDT

The Top Eight Earnings for the Week Ahead

Jon OggEarnings season is far from over, but roughly three quarters of the stocks in the Standard & Poor’s 500 Index…

Paul Ausick | May 2, 2014 at 8:55 AM EDT

AstraZeneca Declares Pfizer Bid ‘Inadequate’

British drug maker AstraZeneca once again rejected a takeover bid from U.S. pharmaceutical giant Pfizer, this one worth $106 billion…

Paul Ausick | Apr 28, 2014 at 4:01 PM EDT

The 4 Stocks That Led Markets Higher

thinkstockApril 28, 2014: Markets opened higher on Monday with little economic data to drive the market either up or down.…

cgblaine22 | Apr 26, 2014 at 8:30 AM EDT

Biotech: The Poster Child for Market Volatility in 2014

The NYSE Arca Biotechnology Index fell nearly 9% between a peak on Jan. 22 and a low on Feb. 5.…

Jon C. Ogg | Apr 23, 2014 at 8:50 AM EDT

UBS Top Stocks to Buy Working for Cancer Cures

In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are…

Paul Ausick | Apr 21, 2014 at 4:40 PM EDT

The 4 Stocks That Boosted Markets

thinkstockApril 21 2014: Markets opened higher on Monday but there wasn’t a lot of action as the only data out…

Jon C. Ogg | Apr 21, 2014 at 1:25 PM EDT

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

ThinkstockIt is not that common that you hear about mergers in the $50 billion range. But what about when you…

Jon C. Ogg | Apr 16, 2014 at 10:40 AM EDT

Why Lpath Could Rise 300%

Canaccord Genuity is one of the few firms that are willing to cover small-cap biotech and emerging pharma stocks. Sometimes…

Paul Ausick | Apr 7, 2014 at 4:27 PM EDT

The 4 Stocks That Slammed the Market

thinkstockApril 7, 2014: Markets opened lower on Monday and were on a downhill slide all day long. Momentum stocks again…

Jon C. Ogg | Apr 7, 2014 at 11:00 AM EDT

FDA Keeps Driving Up Future Cost of Inhalable Insulin

While the FDA has been far from a friend to MannKind over the past few years, the latest FDA panel…

1 … 64 65 66 67 68 … 98

Pfizer : PFE

All Pfizer Articles

The Best-Selling Products of All Time

The 4 Stocks That Tanked the Market

Cross-Border Premium Implications in Merck-Bayer Transaction

The 4 Stocks That Moved the Markets

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

The Top Eight Earnings for the Week Ahead

AstraZeneca Declares Pfizer Bid ‘Inadequate’

The 4 Stocks That Led Markets Higher

Biotech: The Poster Child for Market Volatility in 2014

UBS Top Stocks to Buy Working for Cancer Cures

The 4 Stocks That Boosted Markets

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

Why Lpath Could Rise 300%

The 4 Stocks That Slammed the Market

FDA Keeps Driving Up Future Cost of Inhalable Insulin

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

SLRC faces rate headwinds yet keeps dividend flat; here’s what’s propping up the stock

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

Pfizer : PFE

All Pfizer Articles

The Best-Selling Products of All Time

The 4 Stocks That Tanked the Market

Cross-Border Premium Implications in Merck-Bayer Transaction

The 4 Stocks That Moved the Markets

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

The Top Eight Earnings for the Week Ahead

AstraZeneca Declares Pfizer Bid ‘Inadequate’

The 4 Stocks That Led Markets Higher

Biotech: The Poster Child for Market Volatility in 2014

UBS Top Stocks to Buy Working for Cancer Cures

The 4 Stocks That Boosted Markets

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

Why Lpath Could Rise 300%

The 4 Stocks That Slammed the Market

FDA Keeps Driving Up Future Cost of Inhalable Insulin

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

SLRC faces rate headwinds yet keeps dividend flat; here’s what’s propping up the stock

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up